In 2025, Seppic has chosen to draw inspiration from cinema and the emotions it evokes to create new cosmetic formulations, particularly for In-cosmetics. Seppic will be presenting a collection of six formulas, whose textures and concepts are reminiscent of blockbuster films, transforming them into inspiring formulations for skin care, hair care and nutricosmetics, for truly sensory experiences.
As a sneak peek at the collection, which will be unveiled during the tradeshow, Seppic presents the formula Ode to Mother Nature. Inspired by the movie “Avatar”, this light green thick skincare cream is nourishing and has a medium to long playtime. After massage, the skin remains soft, comfortable and not greasy.
With a naturalness profile of 99.1%*, this inspiring formula was developed by Seppic's teams based on biomimicry. Used as an emulsifier, the organisation of Montanov™ 202 (Arachidyl behenyl alcohol, Arachidyl glucoside) amphiphilic molecules into lamellar layers, known as liquid crystals, improves both the stability and compatibility of the formulation with the skin. Those lipids having a similar structure to skin, Montanov™ 202-based emulsions offer biomimetic textures.
Join Seppic at In-cosmetics 2025 Amsterdam the 08-10 of April at the booth 5D110 to guess which other movies have inspired the whole beauty collection.
*according to ISO 16128
Seppic in brief
A subsidiary of Air Liquide Healthcare, Seppic designs, produces and distributes a wide range of specialty ingredients used in cosmetics, nutraceuticals, pharmaceuticals, veterinary and industrial products. Seppic employs nearly 900 people, including 110 dedicated to innovation, and supports its customers in 100 countries through its subsidiaries and network of distributors. Thanks to an approach to research and innovation focused on acting responsibly and serving its stakeholders, Seppic works every day to put science at the service of all: Seppic, science that cares. www.seppic.com
Healthcare activities at Air Liquide
Air Liquide Healthcare is a world leader in medical gases, home healthcare services and specialty ingredients. Our 16,500 employees support 2 million chronic patients and provide medical gases and related services to 20,000 hospitals and new care facilities, as well as 140,000 healthcare professionals. Committed to working alongside professionals and health institutions, our patient-centered approach is based on the principles of Value-based Healthcare, which aims to improve the benefits experienced by patients, at the best cost to society, thus contributing to a more efficient and virtuous system.
Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 60 countries with 66,300 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition—particularly with hydrogen—and takes action to progress in areas of healthcare, digital and high technologies.
Air Liquide’s revenue amounted to more than 27.5 billion euros in 2023. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.
